This single-center retrospective study assessed the cumulative radiation exposure to the left and right eyes of the primary operator when using a radial artery approach.
On the first day of Dermatology Week, Dr Vincent Richer, a Vancouver-based dermatologist, offered a practical framework for minimizing post-inflammatory pigment alteration.
Dr Cohen explores the association between psoriasis and increased malignancy risk, particularly keratinocyte carcinoma (BCC and SCC), lymphoma, bladder cancer, and lung adenocarcinoma.
The authors performed a 2-arm randomized controlled trial to compare the time, efficacy and safety outcomes between an antegrade wiring (AW) strategy using a first-choice…
According to updated results from the phase 3 CodeBreaK 300 study, 960 mg of sotorasib plus panitumumab is preferable to 240 mg among patients with…
VDM spoke with Dr Powell to discuss the surprising results from the STRIDE study, which looked at the use of the Indigo Aspiration System (Penumbra)…
The FDA approved retifanlimab plus chemotherapy for patients with previously untreated patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal,…
The Disease State Update: Multiple Myeloma Disease State Hub from Oncology offers relevant news and insights for medical professionals.
Emmy Graber, MD, MBA, detailed the underrecognized ocular side effects of isotretinoin and shared practical strategies for dermatologists to better counsel and manage patients.
On May 14, 2025, the US Food and Drug Administration approved telisotuzumab vedotin for previously treated patients with advanced non-small cell lung cancer with high…
According to results from a phase 2a study, zanidatamab plus palbociclib and fulvestrant demonstrated promising efficacy and safety among previously treated patients with HR-positive, HER2-positive…
